Abstract 51P
Background
Chromosomal instability (CIN) is hallmark of cancer associated to progression and aggressiveness in prostate cancer (PCa). In the search of the mechanisms controlling CIN, long non-coding RNAs (lncRNAs) have shown to play important roles in maintaining genome stability, nevertheless, characterization of these transcripts and the networks they control in CIN regulation is still poorly understood.
Methods
RNA-seq data from the prostate cell lines PrEC (stable) and LNCaP (unstable) was analyzed to find novel lncRNAs associated with CIN. Afterwards, experimental validation of the results in PrEC and LNCaP was performed with RT-qPCR and western blot. For the functional experiments, lncRNA knockdown (KD) was performed by transfecting cells with antisense oligonucleotides (ASOs) targeting the lncRNA of interest, followed by karyotyping to assess CIN in the transfected cells. Confirmation of the lncRNA KD was performed by qPCR.
Results
After analyzing and comparing RNA-Seq data from PrEC and LNCaP, a novel lncRNA was discovered in chromosome 3. This nuclear-retained transcript is adjacent to the protein coding gene RFC4, a gene associated to CIN that participates in DNA repair and replication. RT-qPCR analysis showed that while the lncRNA is upregulated in PrEC, RFC4 is downregulated, the opposite pattern was found in LNCaP, suggesting the lncRNA as a cis-repressor of RFC4. The functional experiments confirmed that the lncRNA is a transcriptional repressor of RFC4 but also a regulator of genome stability. After KD of the lncRNA in the stable cell line PrEC, an increase in RFC4 expression was observed as well as an increased number of tetraploid cells, suggesting CIN induction after lncRNA KD. To understand how the lncRNA regulates genome stability, RNA-Seq was performed in the KD experiments showing that lncRNA KD induced disruption of different pathways needed for proper DNA replication and chromosome segregation.
Conclusions
Together our results indicate that the novel lncRNA is a regulator of CIN through regulation of RFC4 and pathways important for maintaining genome stability. The lncRNA adjacent to the protein coding gene RFC4 could be a novel biomarker for PCa progression.
Editorial acknowledgement
Clinical trial identification
Legal entity responsible for the study
Unidad de Investigación Biomédica en Cáncer - Instituto Nacional de Cancerología - Instituto de Investigaciones Biomédicas - UNAM.
Funding
Unidad de Investigación Biomédica en Cáncer - Instituto Nacional de Cancerología - Instituto de Investigaciones Biomédicas - UNAM - CONACyT.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
94P - Harnessing circulating tumor DNA in bronchoalveolar lavage fluid for precise molecular diagnosis of NSCLC
Presenter: Frank Borm
Session: Cocktail & Poster Display session
Resources:
Abstract
95P - Automatic data processing to identify EGFR mutations in pathology reports of patients with non-small cell lung cancer (NSCLC)
Presenter: Betzabel Cajiao Garcia
Session: Cocktail & Poster Display session
Resources:
Abstract
96P - Analysis of concordance between microsatellite instability by next generation sequencing (NGS-MSI) and mismatch repair deficiency by immunohistochemistry (IHC-MMR) in endometrial cancer (EC) patients
Presenter: Simona Duranti
Session: Cocktail & Poster Display session
Resources:
Abstract
97P - Prospects of liquid biopsy in determining prognosis in children with HGG and DIPG
Presenter: Olga Regentova
Session: Cocktail & Poster Display session
Resources:
Abstract
98P - Liquid biopsy in NSCLC: A promising tool to predict immunotherapy response
Presenter: Ana Fernández
Session: Cocktail & Poster Display session
Resources:
Abstract
99P - Comprehensive genomic sequencing as an ancillary diagnostic tool for pathologists
Presenter: Dan Miller
Session: Cocktail & Poster Display session
Resources:
Abstract
100P - Standard serum biomarkers to help predict a cancer diagnosis in patients with non-specific symptoms: Data from Guy´s rapid diagnostic clinic
Presenter: Maria Monroy Iglesias
Session: Cocktail & Poster Display session
Resources:
Abstract
101P - Patient-derived organoids to optimize CDK4/6 inhibitor-based treatment selection in early breast cancer
Presenter: Carla Alves
Session: Cocktail & Poster Display session
Resources:
Abstract
102P - MicroRNAs in urine and saliva as non-invasive biomarkers of minimal residual disease in pediatric acute lymphoblastic leukemia
Presenter: Alejandra Pando-Caciano
Session: Cocktail & Poster Display session
Resources:
Abstract
103P - MSI detection by NGS using tumor samples and liquid biopsy for patients with solid tumors: A single institution experience
Presenter: Alexandra Lebedeva
Session: Cocktail & Poster Display session
Resources:
Abstract